Grifols SA’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the ...

A Spanish court yesterday said it was investigating the US hedge fund Gotham City for allegedly publishing “misleading” ...

A Spanish court yesterday said it was investigating the US hedge fund Gotham City for allegedly publishing “misleading” ...

Grifols (GRFS) informs that its board has held an extraordinary meeting this afternoon “without the intervention of the conflicted board ...

Spanish drug maker Grifols said its board would hold an extraordinary meeting to review Brookfield Capital Partners' offer to take the company private, adding that its transaction committee considers ...

Grifols SA’s board of directors said it won’t recommend that shareholders accept Brookfield Asset Management’s indicative ...

ADRs fell ~6% on Tuesday after its board of directors declined to recommend Brookfield Asset Management's (NYSE:BAM) ...

Grifols said on Tuesday that Canadian investment fund Brookfield's potential 6.45 billion euro ($6.8 billion) offer ...

Brookfield Asset Management Ltd. is considering a €6.45 billion (US$6.9 billion) bid for Grifols SA, with the drug maker’s ...

Brookfield Asset Management is considering a €6.45 billion ($6.9 billion) bid for Grifols SA, with the drug maker’s board set ...

Mason Capital Management LLC ("Mason"), a registered investment advisor to funds and accounts holding approximately 2.1% of ...

Grifols is anticipating a period of strong growth on the back of its recently FDA-approved intravenous immunoglobulin product ...